Glucose Tolerance in Healthy Overweight Adults
Glucose Tolerance in Healthy Overweight Adults
The primary objective is to compare the postprandial glycemic response of healthy overweight
 adults after consuming an amino acid drink mix versus a control drink.
Inclusion Criteria:

 1. Fasting blood glucose level of ≥ 70mg/dL and ≤ 125 mg/dL.

 2. Subject states that he/she does not have type 1 or 2 diabetes.

 3. Subject is overweight as defined as waist circumference ≥ 101 cm (40 inches) male; ≥
 88 cm (35 inches) female.

 4. Subject's BMI is ≥ 25 kg/m2.

 5. Subject's blood pressure is < 140 mm Hg systolic and < 90 mm Hg diastolic.

 6. Subject is between 20 and 45 years of age, inclusive.

 7. Subject is a male or a non-pregnant, non-lactating female, at least 6 weeks postpartum
 prior to screening visit.

 8. If female is of childbearing potential, is practicing birth control

 9. If subject is on a chronic medication such as a thyroid medication or hormone therapy,
 has been on constant dosage for at least two months prior to screening visit.

 Exclusion Criteria:

 1. Subject is eating a low carbohydrate diet such as Atkins, Zone, or South Beach diet
 plan.

 2. Subject states that he/she has current infection, has had inpatient surgery, or
 corticosteroid treatment in the last 3 months or antibiotics in the last 3 weeks prior
 to screening visit.

 3. Subject states that he/she has an active malignancy.

 4. Subject states that he/she has had a significant cardiovascular event ≤ six months
 prior to screening visit; or stated history of congestive heart failure.

 5. Subject states that he/she has end-stage organ failure or is status post organ
 transplant.

 6. Subject states that he/she has a history of renal disease.

 7. Subject states that he/she has current hepatic disease.

 8. Subject states that he/she has a chronic, contagious, infectious disease, such as
 active tuberculosis, Hepatitis B or C, or HIV.

 9. Subject has taken/is currently taking any herbals, dietary supplements, or medications
 during the past four weeks prior to screening visit that could profoundly affect blood
 glucose.

 10. Subject has taken/is currently taking any herbals, dietary supplements, or medications
 during the past four weeks prior to screening visit to control hypertension or
 cholesterol.

 11. Subject states that he/she has clotting or bleeding disorders.